Table 2.
Disease | Genetic defect/presumed pathogenesis | Inheritance | Circulating T cells | Circulating B cells | Serum Ig | Associated features | OMIM number |
---|---|---|---|---|---|---|---|
1. Congenital thrombocytopenia | |||||||
(a) Wiskott– Aldrich syndrome (WAS) | Mutations in WAS; cytoskeletal, and immunologic synapse defect affecting hematopoietic stem cell derivatives | XL | Progressive decrease, abnormal lymphocyte responses to anti-CD3 | Normal | Decreased IgM: antibody to polysaccharides particularly decreased; often increased IgA and IgE | Thrombocytopenia with small platelets; eczema; lymphoma; autoimmune disease; IgA nephropathy; bacterial and viral infections. XL thrombocytopenia is a mild form of WAS, and XL neutropenia is caused by missense mutations in the GTPase binding domain of WASP | 301000 |
(b) WIP deficiencya | Mutations in WIPF1; cytoskeletal and immunologic synapse defect affecting hematopoietic stem cell derivatives | AR | Reduced, defective lymphocyte responses to anti-CD3 | Low | Normal, except for increased IgE | Recurrent infections; eczema; thrombocytopenia. WAS-like phenotype | 614493 |
2. DNA repair defects (other than those in Table 1) | |||||||
(a) Ataxia–telangiectasia | Mutations in ATM; disorder of cell cycle checkpoint; and DNA double-strand break repair | AR | Progressive decrease | Normal | Often decreased IgA, IgE, and IgG subclasses; increased IgM monomers; antibodies variably decreased | Ataxia; telangiectasia; pulmonary infections; lymphoreticular and other malignancies; increased alpha fetoprotein and increased radiosensitivity; chromosomal instability | 208900 |
(b) Ataxia–telangiectasia-like disease (ATLD)a | Hypomorphic mutations in MRE11; disorder of cell cycle checkpoint and DNA double-strand break repair | AR | Progressive decrease | Normal | Antibodies variably decreased | Moderate ataxia; pulmonary infections; severely increased radiosensitivity | 604391 |
(c) Nijmegen breakage syndrome | Hypomorphic mutations in NBS1 (Nibrin); disorder of cell cycle checkpoint and DNA double-strand break repair | AR | Progressive decrease | Variably reduced | Often decreased IgA, IgE, and IgG subclasses; increased IgM; antibodies variably decreased | Microcephaly; bird-like face; lymphomas; solid tumors; increased radiosensitivity; chromosomal instability | 251260 |
(d) Bloom syndrome | Mutations in BLM; RecQ-like helicase | AR | Normal | Normal | Reduced | Short stature; bird-like face; sun-sensitive erythema; marrow failure; leukemia; lymphoma; chromosomal instability | 210900 |
(e) Immunodeficiency with centromeric instability and facial anomalies (ICF) | Mutations in DNA methyltransferase DNMT3B (ICF1) resulting in defective DNA methylation | AR | Decreased or normal; responses to PHA may be decreased | Decreased or normal | Hypogamma globulinemia; variable antibody deficiency | Facial dysmorphic features; macroglossia; bacterial/opportunistic infections; malabsorption; cytopenias; malignancies; multiradial configurations of chromosomes 1, 9, 16; no DNA breaks | 242860 |
(f) Immunodeficiency with centromeric instability and facial anomalies (ICF) | Mutations in ZBTB24 (ICF2) | AR | Decreased or normal; responses to PHA may be decreased | Decreased or normal | Hypogamma globulinemia; variable antibody deficiency | Facial dysmorphic features; macroglossia; bacterial/opportunistic infections; malabsorption; cytopenias; malignancies; multiradial configurations of chromosomes 1, 9, 16 | 242860 |
(g) PMS2 deficiency | Mutations in PMS2, resulting in class switch recombination deficiency due to impaired mismatch repair | AR | Normal | Switched and non-switched B cells are reduced | Low IgG and IgA, elevated IgM, abnormal antibody responses | Recurrent infections; café-au-lait spots; lymphoma, colorectal carcinoma, brain tumor | 600259 |
(h) RNF168 deficiencya | Mutations in RNF168, resulting in defective DNA double-strand break repair | AR | Normal | Normal | Low IgG or low IgA | Short stature; mild motor control to ataxia and normal intelligence to learning difficulties; mild facial dysmorphism to microcephaly; increased radiosensitivity | 611943 |
(i) MCM4 deficiency | Mutations in MCM4 (minichromosome maintenance complex component 4) gene involved in DNA replication and repair | AR | Normal | Normal | Normal | Viral infections (EBV, HSV, VZV) Adrenal failure Short stature | 609981 |
3. Thymic defects with additional congenital anomalies | |||||||
(a) DiGeorge anomaly | Contiguous gene defect in 90% affecting thymic development; may also be due to heterozygous mutation in TBX1 (chromosome 22q11.2 deletion or TBX1 haploinsufficient syndrome) | De novo defect (majority) or AD | Decreased or normal; 5% have <1500 CD3 T cells/μL | Normal | Normal or decreased | Hypoparathyroidism, conotruncal malformation; abnormal facies; large deletion (3 Mb) in 22q11.2 (or rarely a deletion in 10p) | 188400 |
(b) CHARGE syndrome | Variable defects of the thymus and associated T cell abnormalities often due to deletions or mutations in CHD7, SEMA3E, or as yet unknown genes | De novo defect (majority) or AD | Decreased or normal; some have <1500 CD3 T cells/μL | Normal | Normal or decreased | Coloboma, heart anomaly, choanal atresia, retardation, genital and ear anomalies | 214800 608892 |
4. Immune-osseous dysplasias | |||||||
(a) Cartilage hair hypoplasia | Mutations in RMRP (RNase MRP RNA) involved in processing of mitochondrial RNA and cell cycle control | AR | Varies from severely decreased (SCID) to normal; impaired lymphocyte proliferation | Normal | Normal or reduced. Antibodies variably decreased | Short-limbed dwarfism with metaphyseal dysostosis, sparse hair, bone marrow failure, autoimmunity, susceptibility to lymphoma and other cancers, impaired spermatogenesis, neuronal dysplasia of the intestine | 250250 |
(b) Schimke syndrome | Mutations in SMARCAL1 involved in chromatin remodeling | AR | Decreased | Normal | Normal | Short stature, spondiloepiphyseal dysplasia, intrauterine growth retardation, nephropathy; bacterial, viral, and fungal infections; may present as SCID; bone marrow failure | 242900 |
5. Hyper-IgE syndromes (HIES) | |||||||
(a) AD-HIES (Job’s syndrome) | Dominant-negative heterozygous mutations in STAT3 | AD Often de novo defect | Normal Th-17 and T follicular helper cells decreased | Normal Switched and non-switched memory B cells are reduced; BAFF level increased | Elevated IgE; specific antibody production decreased | Distinctive facial features (broad nasal bridge), eczema, osteoporosis, and fractures, scoliosis, delay of shedding primary teeth, hyperextensible joints, bacterial infections (skin and pulmonary abscesses, pneumatoceles) due to Staphylococcus aureus, candidiasis, aneurysm formation | 147060 |
(i) Tyk2 deficiencya | Mutation in TYK2 | AR | Normal, but multiple cytokine signaling defect | Normal | (±) Elevated IgE | Susceptibility to intracellular bacteria (Mycobacteria, Salmonella), fungi, and viruses | 611521 |
(ii) DOCK8 deficiency | Mutations in DOCK8 – regulator of intracellular actin reorganization | AR | Decreased impaired T lymphocyte proliferation | Decreased, low CD27+ memory B cells | Low IgM, increased IgE | Low NK cells with impaired function, hypereosinophilia, recurrent infections; severe atopy, extensive cutaneous viral and bacterial (staph.) infections, susceptibility to cancer | 243700 |
6. Dyskeratosis congenital (DKC) | |||||||
(a) XL-DKC | Mutations in dyskerin (DKC1) (Hoyeraal–Hreidarsson syndrome) | XL | Progressive decrease | Progressive decrease | Variable | Intrauterine growth retardation, microcephaly, nail dystrophy, recurrent infections, digestive tract involvement, pancytopenia, reduced number and function of NK cells | 305000 |
(b) AR-DKC due to NHP2 deficiency | Mutation in NOLA2 (NHP2) | AR | Decreased | Variable | Variable | Pancytopenia, sparse scalp hair and eyelashes, prominent periorbital telangiectasia, and hypoplastic/dysplastic nails | 613987 |
(c) AR-DKC due to NOP10 deficiency | Mutation in NOLA3 (NOP10 PCFT) | AR | Decreased | Variable | Variable | Pancytopenia, sparse scalp hair and eyelashes, prominent periorbital telangiectasia, and hypoplastic/dysplastic nails | 224230 |
(d) AR-DKC due to RTEL1 deficiency | Mutation in (RTEL1) | AR | Decreased | Variable | Variable | Pancytopenia, sparse scalp hair and eyelashes, prominent periorbital telangiectasia, and hypoplastic/dysplastic nails | 608833 |
(e) AD-DKC due to TERC deficiency | Mutation in TERC | AD | Variable | Variable | Variable | Reticular hyperpigmentation of the skin, dystrophic nails, osteoporosis premalignant leukokeratosis of the mouth mucosa, palmar hyperkeratosis, anemia, pancytopenia | 127550 |
(f) AD-DKC due to TERT deficiency | Mutation in TERT | AD | Variable | Variable | Variable | Reticular hyperpigmentation of the skin, dystrophic nails, osteoporosis premalignant leukokeratosis of the mouth mucosa, palmar hyperkeratosis, anemia, pancytopenia | 614742 |
(g) AD-DKC due to TINF2 deficiency | Mutation in TINF2 | AD | Variable | Variable | Variable | Reticular hyperpigmentation of the skin, dystrophic nails, osteoporosis premalignant leukokeratosis of the mouth mucosa, palmar hyperkeratosis, anemia, pancytopenia | 613990 |
7. Defects of vitamin B12 and folate metabolism | |||||||
(a) TCN2 deficiency | Mutation in TCN2; encodes transcobalamin, a transporter of cobalamin into blood cells | AR | Normal | Variable | Decreased | Megaloblastic anemia, pancytopenia, untreated for prolonged periods results in mental retardation | 275350 |
(b) SLC46A1 deficiency | Mutation in SLC46A1; a proton coupled folate transporter | AR | Variable numbers and activation profile | Variable | Decreased | Megaloblastic anemia, failure to thrive untreated for prolonged periods results in mental retardation | 229050 |
(c) MTHFD1a deficiency | Mutations in MTHFD1; essential for processing of single-carbon folate derivatives | AR | Low | Low | Decreased | Megaloblastic anemia, failure to thrive neutropenia, seizures, mental retardation | |
8. Comel–Netherton syndrome | Mutations in SPINK5 resulting in lack of the serine protease inhibitor LEKTI, expressed in epithelial cells | AR | Normal | Switched and non-switched B cells are reduced | Elevated IgE and IgA | Congenital ichthyosis, bamboo hair, atopic diathesis, increased bacterial infections, failure to thrive | 256500 |
Antibody variably decreased | |||||||
9. Winged helix deficiency (Nude)a | Defects in forkhead box N1 transcription factor encoded by FOXN1 | AR | Markedly decreased | Normal | Decreased | Alopecia, abnormal thymic epithelium, impaired T cell maturation | 600838 |
10. ORAI-I deficiencya | Mutation in ORAI1, a Ca++ release-activated channel (CRAC) modulatory component | AR | Normal number, but defective TCR-mediated activation | Normal | Normal | Autoimmunity, anhydrotic ectodermic dysplasia, non-progressive myopathy defective TCR-mediated activation | 610277 |
11. STIM1 deficiencya | Mutations in STIM1, a stromal interaction molecule 1 | AR | Normal number, but defective TCR-mediated activation | Normal | Normal | Autoimmunity, anhydrotic ectodermal dysplasia, non-progressive myopathy defective TCR-mediated activation | 605921 |
12. STAT5b deficiencya | Mutations in STAT5B, signal transducer, and transcription factor, essential for normal signaling from IL-2 and 15, key growth factors for T and NK cells | AR | Modestly decreased | Normal | Normal | Growth-hormone insensitive dwarfism | 245590 |
Dysmorphic features | |||||||
Eczema | |||||||
Lymphocytic interstitial pneumonitis, autoimmunity | |||||||
13. Hepatic veno-occlusive disease with immunodeficiency (VODI) | Mutations in SP110 | AR | Normal (decreased memory T cells) | Normal (decreased memory B cells) | Decreased IgG, IgA, IgM, absent germinal centers, absent tissue plasma cells | Hepatic veno-occlusive disease; Pneumocystis jiroveci pneumonia; susceptibility to CMV, Candida; thrombocytopenia; hepatosplenomegaly | 235550 |
14. IKAROS deficiencya | Mutation in IKAROS | AD de novo | Normal, but impaired lymphocyte proliferation | Absent | Presumably decreased | Anemia, neutropenia, thrombocytopenia | Not assigned |
15. FILS syndromea | Mutation in POLE1; defective DNA replication | AR | Low naïve T cells; decreased T cell proliferation | Low memory B cells | Decreased IgM and IgG; lack of antibodies to polysaccharide antigens | Mild facial dysmorphism (malar hypoplasia, high forehead), livedo, short stature; recurrent upper and lower respiratory tract infections, recurrent pulmonary infections, and recurrent meningitis | 615139 |
16. Immunodeficiency with multiple intestinal atresias | Mutation in TTC7A [tetratricopeptide repeat (TPR) domain 7A] protein of unknown function | AR | Variable, but sometimes absent | Normal | Decreased | Multiple intestinal atresias, often with intrauterine polyhydramnios and early demise; some with SCID phenotype | 243150 |
SCID, severe combined immune deficiencies; XL, X-linked inheritance; AR, autosomal recessive inheritance; AD, autosomal dominant inheritance; MSMD, Mendelian susceptibility of mycobacterial disease.
aTen or fewer unrelated cases reported in the literature.
T and B cell number and function in these disorders exhibit a wide range of abnormality; the most severely affected cases meet diagnostic criteria for SCID or leaky SCID and require immune system restoring therapy such as allogeneic hematopoietic cell transplantation. While not all DOCK8-deficient patients have elevated serum IgE, most have recurrent viral infections and malignancies as a result of combined immunodeficiency. AR-HIES due to Tyk2 deficiency is also listed in Table 6, because of its association with atypical mycobacterial disease resulting in MSMD. Riddle syndrome is caused by mutations in a gene involved in DNA double-strand break repair and is associated with hypogammaglobulinemia. Autosomal dominant and autosomal recessive forms of dyskeratosis congenita are included in this table. IKAROS-deficiency represents a single prematurely born infant who died at the age of 87 days and who had absent B and NK cells and non-functional T cells.